Cannabinoids for treatment of glaucoma

Current Opinion in Ophthalmology

Volumn 27, Issue 2, 2016, Pages 146-150

  Novack, Gary D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PHARMALOGIC DEVELOPMENT INC   (United States)

Author keywords

cannabinoids; glaucoma; intraocular pressure; marijuana

Indexed keywords

11 HYDROXYDRONABINOL; CANNABIDIOL; CANNABINOL; CANNABIS; DELTA8 TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOL; ANTIHYPERTENSIVE AGENT; CANNABINOID;

ANTIHYPERTENSIVE ACTIVITY; CANNABIS SMOKING; CARCINOGENICITY; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; GLAUCOMA; HUMAN; HYPOTENSION; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; TERATOGENICITY; UNITED STATES; DRUG EFFECTS; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY;

ANTIHYPERTENSIVE AGENTS; CANNABINOIDS; CANNABIS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; TONOMETRY, OCULAR;

EID: 84957048798     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0000000000000242     Document Type: Review

References (26)

1. Ritch R. Complementary therapy for the treatment of glaucoma: A perspective. Ophthalmol Clin North Am 2005; 18:597-609.
2. Bower TN, Muhsen S, Overbury O, et al. Canadian ophthalmologists opinions concerning complementary and alternative medicine (CAM) use in glaucoma. J Glaucoma 2014; 23:430-434.
3. Buys YM, Rafuse PE. Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma. Can J Ophthalmol 2010; 45:324-326.
4. Rhee DJ, Katz LJ, Spaeth GL, Myers JS. Complementary and alternative medicine for glaucoma. Surv Ophthalmol 2001; 46:43-55.
5. Joy JE, Watson SJ Jr, Benson JA. Marijuana and medicine: Assessing the science base. Washington, D.C.: National Academy Press; 1999.
6. Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. JAMA 1971; 217:1392.
7. Merritt JC, Crawford WJ, Alexander PC, et al. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology 1980; 87:222-228.
8. Merritt JC, Cook CE, Davis KH. Orthostatic hypotension after delta 9-Tetrahydrocannabinol marihuana inhalation. Ophthalmic Res 1982; 14:124-128.
9. Jones RT, Benowitz NL, Herning RI. Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 1981; 21:143S-152S.
10. Green K, Roth M. Ocular effects of topical administration of delta 9-Tetrahydrocannabinol in man. Arch Ophthalmol 1982; 100:265-267.
11. Jay WM, Green K. Multiple-drop study of topically applied 1% delta 9-Tetrahydrocannabinol in human eyes. Arch Ophthalmol 1983; 101:591-593.
12. Spitze AR, Lattanzio FA, Jr., Allen RC, et al. Human Corneal Penetration by Topical Formulations of the Synthetic Endocannabinoid, WIN 55-212-2. Invest Ophthalmol Vis Sci 46, ARVO E-Abstract 3783. 5-1-2005 Ref Type, Abstract
13. Cooler P, Gregg JM. Effect of delta-9-Tetrahydrocannabinol on intraocular pressure in humans. South Med J 1977; 70:951-954.
14. Newell FW, Stark P, Jay WM, Schanzlin DJ. Nabilone: A pressure-reducing synthetic benzopyran in open-Angle glaucoma. Ophthalmology 1979; 86:156-160.
15. Tiedeman JS, Shields MB, Weber PA, et al. Effect of synthetic cannabinoids on elevated intraocular pressure. Ophthalmology 1981; 88:270-277.
16. Zhan GL, Camras CB, Palmberg PF, Toris CB. Effects of marijuana on aqueous humor dynamics in a glaucoma patient. J Glaucoma 2005; 14:175-177.
17. Kaufman PL. Marijuana and glaucoma [editorial; comment]. Arch Ophthalmol 1998; 116:1512-1513.
18. Green K. Marijuana smoking vs cannabinoids for glaucoma therapy [see comments]. Arch Ophthalmol 1998; 116:1433-1437.
19. Jampel H. American glaucoma society position statement: marijuana and the treatment of glaucoma. J Glaucoma 2010; 19:75-76.
20. Anonymous. American Academy of Ophthalmology Reiterates Position that Marijuana is Not Proven Treatment for Glaucoma. 2015. http://www.aao.org/newsroom/news-releases/detail/american-Academy-of-ophthalmology-reiter ates-posit Accessed 27 June 2014.
21. Tomida I, Azuara-Blanco A, House H, et al. Effect of sublingual application of cannabinoids on intraocular pressure: A pilot study. J Glaucoma 2006; 15:349-353.
22. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A systematic review and meta-Analysis. JAMA 2015; 313:2456-2473.
23. Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA 2015; 313:2474-2483.
24. Le FB, Tyndale RF. Cannabinoids: Friend or foe? Clin Pharmacol Ther 2015; 97:528-531.
25. Abrams DI, Guzman M. Cannabis in cancer care. Clin Pharmacol Ther 2015; 97:575-586.
26. Merritt JC. Glaucoma, hypertension, and marijuana. J Natl Med Assoc 1982; 74:715-716.